Watch the presentation by Caroline Durand, co-founder of Healshape, and Sophie Brac de la Perrière, CEO and co-founder of Healshape, on the theme: Innovating for better care, when science and humanity advance together.
Healshape is a company focused on regenerative medicine for breast reconstruction. It is developing a natural 3D-printed matrix to regenerate patients’ tissue. The project required various types of funding, complex regulatory steps and the construction of a solid ecosystem with medical partnerships and experts. Clinical trials are expected to begin in late 2026, with market access anticipated around 2030, including challenges such as reimbursement and further fundraising.